The Breast Cancer Now research unit at King's College London is entirely focused on studying triple negative breast cancer. This type of breast cancer tends to be more aggressive and is more likely to affect younger and black women.
About our research unit
Our research unit at King’s College London is led by Professor Andrew Tutt, a world leader in the field of triple negative breast cancer.
The unit is made up of 3 research groups, headed by Professor Andrew Tutt, Professor Sophia Karagiannis, and Dr Anita Grigoriadis. They work together to find what drives triple negative breast cancer, where its weaknesses lie, and how to develop new treatments.
Key facts
-
15%
Around 15% of all breast cancers are triple negative. -
12 scientists
There are 12 scientists working across the 3 research groups. -
£1,920
It costs £1920 per day to run our Research Unit.
Impact of the research unit
Triple negative trial
A clinical trial that changed how advanced triple negative breast cancer is treated.
Improving chemo drugs
Scientists found that blocking a molecule called PIM1 could potentially be used to boost chemo.
New targets
Researchers discovered a ‘cancer addiction gene’ that could be a new target to treat the disease.
AI to predict spread
Scientists developed an AI model that can predict if triple negative breast cancer will spread.
